— Completion of IND submission for NDI-219216, a non-covalent WRN inhibitor for treatment of MSI-H tumors, with plans to initiate…
Read More
— Completion of IND submission for NDI-219216, a non-covalent WRN inhibitor for treatment of MSI-H tumors, with plans to initiate…
Read More